Study finds chemotherapy’s link to hearing loss
Toronto, November 9 (ANI): Canadian researchers have found why a common chemotherapy drug results in hearing loss, which contributes to learning difficulties in some childhood cancer patients.
British Columbia experts made progress in the development of a simple saliva or blood test that can foretell who is most likely to develop the problem.
Michael Hayden, director of the Centre for Molecular Medicine and Therapeutics at the Child and Family Research Institute in Vancouver, discovered two genetic variations that for children who have them, means they will suffer serious hearing loss after taking the generic drug cisplatin.
“This is personalized genomics. The other challenge is coming up with a test that’s very cheap that can be used at the point of care,” the Globe and Mail quoted him as saying.
Bruce Carleton, co-principal investigator and a senior clinician scientist at the Child and Family Research Institute, said the finding can aid alter treatment for pediatric cancer patients.
He said: “I am really excited about this because for 20 years, I have been trying to figure out this plague in medicine; to dose to toxicity, and then stop. It’s primitive but it’s the best thing we can do…The idea that we could stop therapy before permanent disability occurs is now a possibility.”
The study was published in the journal Nature Genetics. (ANI)
Related Posts
Genetic variations behind increased prostate cancer risk identified
London, Sep 21 (ANI): Taking a major step in prostate cancer research, scientists have found a host of genetic variations that could tell which men are at the highest risk of contracting prostate cancer.
The results come from two studies... |
Drug ‘can shrink lung cancer tumours’
Washington, Nov 11 (ANI): Scientists from the Imperial College of London have found a promising drug for the treatment of an aggressive form of lung cancer.
The drug eliminated small cell lung cancer tumours in 50 percent of mice, and blocked the cells'... |
Gene discovery could guide future breast cancer treatment choices
Scientists at Dana-Farber Cancer Institute have discovered a genetic signature that may help identify patients at high risk of breast cancer recurrence despite been treated with chemotherapy drugs.
According to them, despite their resistance to drugs... |
New gene linked to progressive hearing loss identified
Washington, Sept 4(ANI): Scientists from The Scripps Research Institute have discovered a gene responsible for progressive hearing loss.
The has team found a gene, called Loxhd1, which is necessary for maintaining proper functioning hair cells... |
60-year-old drug may help treat deadly cancers
Washington, Aug 27 (ANI): A drug developed back in 1940s has a potential to treat some of the most deadly cancers, it has emerged.
Scientists from Institute of Cancer Research in London have discovered that methotrexate, a chemotherapy treatment invented... |
Cetuximab drug with chemo may cut death risk in lung cancer patients
Washington, Sept 22 (ANI): Giving drug cetuximab (Erbitux) along with chemotherapy can significantly reduce death risk in lung cancer patients, researchers have found.
The study showed that patients with advanced non-small cell lung cancer who are given... |
